Digital therapeutics can help people make positive and sustainable behavior change that can be as effective as taking a medication. It’s time to break free of the traditional paradigms of disease management and embrace the future by leveraging technology to fully realize the benefits of therapeutics.
How you talk could reveal heart disease or concussions, say researchers and companies developing the novel technology.
There’s long been talk in medicine about the need to listen more to the patient voice — and now that mantra is being taken literally.
Boston-based Sonde Health, a recent spin-out of PureTech Health, has licensed a health-focused voice scanning technology from MIT’s Lincoln Laboratories.
The development of vocal biomarkers to detect things like depression and stress has been an area of interest for some time.
PureTech Health starts companies in cutting-edge areas of biomedical science and often owns them outright. Its latest aims to create software that listens for warning signs of depression in people’s speech patterns.
Sonde Health is developing voice-based technologies capable of diagnosing medical conditions by analyzing vocal biomarkers—acoustic characteristics in the speakers voice.
Life sciences incubator PureTech Health (LON:PRTC), unfazed by the worldwide impact of the U.K.’s vote to leave the European Union, announced its latest venture today: Sonde Health, which aims to use a voice-based technology to diagnose mental and physical ailments.
They’re analyzing audio clips from users’ devices to find mental & physical ailments.
Company licenses MIT technology and collaborates with experts to objectively diagnose and monitor medical concerns through vocal cues.